IL226237B - Compositions for transdermal delivery of active agents - Google Patents
Compositions for transdermal delivery of active agentsInfo
- Publication number
- IL226237B IL226237B IL226237A IL22623713A IL226237B IL 226237 B IL226237 B IL 226237B IL 226237 A IL226237 A IL 226237A IL 22623713 A IL22623713 A IL 22623713A IL 226237 B IL226237 B IL 226237B
- Authority
- IL
- Israel
- Prior art keywords
- compositions
- active agents
- transdermal delivery
- transdermal
- delivery
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000037317 transdermal delivery Effects 0.000 title 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL226237A IL226237B (en) | 2010-11-15 | 2013-05-08 | Compositions for transdermal delivery of active agents |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41360810P | 2010-11-15 | 2010-11-15 | |
| PCT/IL2011/000880 WO2012066537A2 (en) | 2010-11-15 | 2011-11-15 | Compositions for transdermal delivery of active agents |
| IL226237A IL226237B (en) | 2010-11-15 | 2013-05-08 | Compositions for transdermal delivery of active agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL226237A0 IL226237A0 (en) | 2013-07-31 |
| IL226237B true IL226237B (en) | 2019-08-29 |
Family
ID=48917272
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL226237A IL226237B (en) | 2010-11-15 | 2013-05-08 | Compositions for transdermal delivery of active agents |
Country Status (1)
| Country | Link |
|---|---|
| IL (1) | IL226237B (en) |
-
2013
- 2013-05-08 IL IL226237A patent/IL226237B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| IL226237A0 (en) | 2013-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE037897T2 (en) | Compositions for transdermal delivery of active agents | |
| ZA201202855B (en) | Transdermal pharmaceutical compositions comprising active agents | |
| AP3284A (en) | Compositions for targeted delivery of SIRNA | |
| IL228984A0 (en) | Compositions and methods for stabilization of active agents | |
| EP2568975A4 (en) | Film compositions for delivery of actives | |
| GB201121070D0 (en) | composition for delivery of biotherapeutics | |
| HUE042850T2 (en) | Compositions for drug delivery | |
| IL237318B (en) | Chemical compositions and methods for enhancing transdermal delivery of therapeutic agents | |
| EP2470019A4 (en) | Compositions for delivery of insoluble agents | |
| EP2688561A4 (en) | Transdermal compositions comprising an active agent layer and an active agent conversion layer | |
| IL221959A (en) | Propynylaminoindan transdermal compositions | |
| ZA201306643B (en) | Formulation comprising phenylaminopyrimidine derivatives as active agent | |
| GB201001203D0 (en) | Use of pharmaceutically active compounds | |
| IL226237A0 (en) | Compositions for transdermal delivery of active agents | |
| GB201001900D0 (en) | Transdermal delivery composition | |
| GB201000988D0 (en) | Compositions to deliver active ingredients |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |